Professor Andrew Godkin
Prosiectau fel Prif Ymchwiliwr
- A pilot study to assess the effect of regulatory T cell depletion combined with vaccination in patients with colorectal cancer (01.10.2010 - 30.09.2013)
- BICCC (01.05.2022 - 30.04.2027)
- Brief intervention with cyclophosphamide in patients with Colorectal cancer (CRC) who have completed treatment (BICCC) (01.09.2018 - 31.08.2022)
- Designing unconventional peptide modifications to universally enhance cd4+ t-cell activation (08.05.2018 - 01.01.2025)
- Development of immune-modulators for preventing immune suppression by cancer-associated LAG3CF4 T-cells (01.01.2016 - 31.01.2019)
Prosiectau fel Cyd-Ymchwiliwr
- Biomedical Vacation Scholarships (01.07.2009 - 01.09.2009)
- Cardiff University Infection and Immunity Annual meeting 2022 (01.09.2022 - 17.02.2023)
- Coordinating COVID-19 asymptomatic testing programmes in university settings: providing insight on acquired immunity across the student population (01.01.2021 - 31.03.2021)
- Deciphering the molecular rules that govern CD4+ T cell responses to tumour associated antigen peptides to enhance anti-tumour immunity through neo-modification (01.10.2022 - 31.03.2025)
- Development of bespoke T cell-inducing adenovirus-based vaccine vectors (01.08.2022 - 31.03.2023)